A small proportion of the sIg+ B lymphocytes in peripheral lymphoid organs [22% in spleen and 6% in lymph node (LN)] in rat carries the Thy-1 antigen. These Thy-1+ B cells represent newly formed bone marrow (BM) derived (or immature) B cells. In this study we investigated the kinetic behavior of Thy-1+ and Thy-1- B cells in various lymphoid tissues. The renewal rates of these B cells in young adult rats were determined by continuous administration of 5-bromo-2-deoxyuridine (BrdU) for up to 6 weeks. At several time intervals, Thy-1+ and Thy-1- B cell subpopulations in BM, blood, spleen and popliteal LN were analyzed for the presence of incorporated BrdU, using three-color immunocytology on cytospin preparations. In all tissues studied, the Thy-1+ B cells were rapidly renewed with a rate that varied between 58% (BM) and 22% (LN) per day. Virtually all Thy-1+ B cells were labeled by BrdU within a period of 8-16 days, indicating that all these cells are relatively short-lived. By contrast, the replacement of Thy-1- B cells in these tissues was 30-40 times lower, and ranged between 2.0 and 0.8% per day. In absolute numbers we estimate that 57 million Thy-1+ B cells are renewed per day in the BM whereas only 10 million Thy-1- B cells are replaced in the pool of long-lived peripheral B cells. This implicates a cell loss of 80% at the transition of the Thy-1+ to the Thy-1- B cell stage. The few B cells that actually become incorporated into the pool of mature B cells are most probably selected on the basis of the specificity of their sIg.

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/5.7.735DOI Listing

Publication Analysis

Top Keywords

thy-1+ cells
16
cells
13
thy-1+ thy-1-
12
thy-1- cells
12
cell subpopulations
8
peripheral lymphoid
8
lymphoid tissues
8
thy-1- cell
8
thy-1+
7
thy-1-
5

Similar Publications

Fibrotic focus is a pivotal morphofunctional unit in developing fibrosis in various tissues. For most fibrotic diseases, including progressive forms, the foci are considered unable to remodel and contribute to the worsening of prognosis. Unfortunately, the dynamics of the fibrotic focus formation and resolution remains understudied.

View Article and Find Full Text PDF

Blood-derived APLP1 extracellular vesicles are potential biomarkers for the early diagnosis of brain diseases.

Sci Adv

January 2025

Department of Biotechnology, College of Life Science, CHA University, Gyeonggi-do 13488, Republic of Korea.

Article Synopsis
  • Early detection of neurodegenerative diseases relies on identifying brain-specific biomolecules in blood, and this study explores amyloid precursor-like protein 1 (APLP1) as a new biomarker found in extracellular vesicles (EVs).
  • The research confirms that APLP1 EVs in human blood come from the brain, supported by distinct small RNA patterns and the expression of miRNA targets that are highly present in brain tissue.
  • Validation using special mouse models (Thy-1 GFP M line) alongside data analysis highlights APLP1 EVs' potential as both diagnostic markers and key players in advancing neurodegenerative disease diagnosis.
View Article and Find Full Text PDF

Accumulating evidence demonstrates that alpha-synuclein (α-syn) pathology associated with Parkinson's disease (PD) is not limited to the brain, as it also appears in a select number of peripheral tissues including the liver. In this study, we identified a number of PD-associated α-syn post-translational modifications in the livers of (Thy-1)-h[A30P] mice, a mouse model of familial PD expressing human α-syn harboring the A30P mutation driven by a neuron-specific promoter. , we also demonstrate that human hepatocytes induce post-translational modifications following α-syn fibrillar (PFF) treatment.

View Article and Find Full Text PDF

Objective: This study investigated the role and mechanisms of 1.25(OH)2D3 in proliferative glomerulonephritis and its effect on the regulation of mesangial cells.

Methods: Sixty male SD rats were randomly divided into four groups: control (CG), nephritis (NG), nephritis + 1.

View Article and Find Full Text PDF

Background: Colorectal cancer is the 4th most reported reason for cancer death worldwide. It is a complex and multifaceted disease with diverse histopathological manifestations. CD70 is present on activated immune cells and is upregulated in patients who have finished adjuvant therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!